Advertisement
U.S. Markets open in 7 hrs 32 mins
S&P Futures
5,750.25 +7.00 (+0.12%) Dow Futures
42,008.00 +52.00 (+0.12%) Nasdaq Futures
20,123.25 +37.25 (+0.19%) Russell 2000 Futures
2,230.60 -0.50 (-0.02%) Crude Oil
71.41 -0.06 (-0.08%) Gold
2,746.20 0.00 (0.00%)
RedHill Biopharma Ltd. (RDHL)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 10.18M |
| Enterprise Value | 3.46M |
| Trailing P/E | 0.10 |
| Forward P/E | 1.43k |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.75 |
| Price/Book (mrq) | 166.89 |
| Enterprise Value/Revenue | 0.93 |
| Enterprise Value/EBITDA | 0.30 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 3.67 |
| 52-Week Change 3 | N/A |
| S&P500 52-Week Change 3 | N/A |
| 52 Week High 3 | 82.00 |
| 52 Week Low 3 | 6.80 |
| 50-Day Moving Average 3 | 8.89 |
| 200-Day Moving Average 3 | 11.21 |
Share Statistics
| Avg Vol (3 month) 3 | 79.01k |
| Avg Vol (10 day) 3 | 12.92k |
| Shares Outstanding 5 | 1.28M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 11.09B |
| % Held by Insiders 1 | 0.00% |
| % Held by Institutions 1 | 11.49% |
| Shares Short (Oct 15, 2024) 4 | 7.36k |
| Short Ratio (Oct 15, 2024) 4 | 0.31 |
| Short % of Float (Oct 15, 2024) 4 | 0.65% |
| Short % of Shares Outstanding (Oct 15, 2024) 4 | 0.57% |
| Shares Short (prior month Sep 13, 2024) 4 | 49.76k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Jun 30, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -328.46% |
Management Effectiveness
| Return on Assets (ttm) | -44.88% |
| Return on Equity (ttm) | -1,708.61% |
Income Statement
| Revenue (ttm) | 3.71M |
| Revenue Per Share (ttm) | 4.73 |
| Quarterly Revenue Growth (yoy) | -28.40% |
| Gross Profit (ttm) | N/A |
| EBITDA | -20.94M |
| Net Income Avi to Common (ttm) | -30.17M |
| Diluted EPS (ttm) | -294.48 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.28M |
| Total Cash Per Share (mrq) | 0 |
| Total Debt (mrq) | 558k |
| Total Debt/Equity (mrq) | 914.75 |
| Current Ratio (mrq) | 0.74 |
| Book Value Per Share (mrq) | 0.05 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -24.23M |
| Levered Free Cash Flow (ttm) | -5.39M |
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.